Label: PCXX ONE MINTE BAZOOKA BUBBLEGUM- fluoride treatment gel
-
Contains inactivated NDC Code(s)
NDC Code(s): 62007-002-16 - Packager: Ross Healthcare Inc.
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated November 7, 2017
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- WARNINGS AND PRECAUTIONS
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
PCXX ONE MINTE BAZOOKA BUBBLEGUM
fluoride treatment gelProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:62007-002 Route of Administration topical Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SODIUM FLUORIDE (UNII: 8ZYQ1474W7) (FLUORIDE ION - UNII:Q80VPU408O) FLUORIDE ION 27.2 mg in 1 mg Product Characteristics Color pink Score Shape Size Flavor BUBBLE GUM Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:62007-002-16 1 mg in 1 BOTTLE, PLASTIC; Type 1: Convenience Kit of Co-Package 11/07/2017 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 11/07/2017 Labeler - Ross Healthcare Inc. (244249012) Registrant - Ross Healthcare Inc. (244249012) Establishment Name Address ID/FEI Business Operations Ross Healthcare Inc. 244249012 manufacture(62007-002)
